Posted by on November 18, 2020 11:09 am
Originally From: TowleRoad

Tags: , , , , ,

Pfizer announced Wednesday morning that it would seek approval for its COVID vaccine within days after a final analysis showed better results than those reported last week.

NBC News reports: “The U.S. pharma giant and its German partner said their Phase 3 trial was now complete, and that it found the vaccine was 95 percent effective at preventing symptomatic Covid-19 — up from the 90 percent announced last week. There have been no serious side effects among the 41,135 adults who received two doses, the companies said in a joint statement. The most common reactions were that 3.7 percent of participants experiencing fatigue and 2 percent had a headache, it said.”

“Their vaccine has been tested on 43,500 people in six countries and no safety concerns have been raised,” BBC reported last

READ MORE OF THIS POST AT TowleRoad

Leave a Reply

Your email address will not be published. Required fields are marked *

Live Guys Online Now!
Live Guys Online Now!